PPP1R14A Human

Protein Phosphatase-1 Regulatory Subunit-14A Human Recombinant
Cat. No.
BT437
Source
Escherichia Coli.
Synonyms
Protein phosphatase 1 regulatory subunit 14A, 17 kDa PKC-potentiated inhibitory protein of PP1, CPI17, CPI-17, PPP1INL, PPP1R14A.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant PPP1R14A produced in E.Coli is a single, non-glycosylated polypeptide chain containing 167 amino acids and having a molecular mass of 18kDa. PPP1R14A is fused to a 20 aa His Tag and is purified by conventional chromatography techniques.

Product Specs

Introduction
PPP1R14A, also known as protein phosphatase 1 regulatory subunit 14A, functions as a phosphorylation-dependent inhibitor of smooth muscle myosin phosphatase. This inhibition leads to increased myosin phosphorylation, thereby enhancing smooth muscle contraction without increasing intracellular calcium (Ca2+) concentration. Myosin phosphatase typically reverses myosin light chain (MYL) phosphorylation to induce muscle relaxation. However, during agonist-induced contraction at constant Ca2+ levels, concurrent inhibition of myosin phosphatase by PPP1R14A results in elevated MYL phosphorylation and tension, a phenomenon known as calcium sensitization. Human pregnancy is associated with increased PKN1 expression and CPI-17 phosphorylation in the myometrium, processes in which PPP1R14A may be involved. The gene encoding PPP1R14A is located on chromosome 19q13.13-q13.2. PPP1R14A directly interacts with protein kinase C (PKC) and casein kinase I. Studies have shown that silencing PPP1R14A using siRNA reduces merlin phosphorylation, consequently affecting Ras and ERK activity in human tumor cell lines. The PKC/CPI-17 pathway, potentially modulated by PPP1R14A, plays a role in histamine-induced cytoskeletal rearrangements that compromise the lung microvascular barrier.
Description
This product consists of recombinant PPP1R14A protein produced in E. coli. It is a single, non-glycosylated polypeptide chain with 167 amino acids, resulting in a molecular mass of 18 kDa. The protein includes a 20 amino acid His Tag sequence for purification purposes and is purified using standard chromatography techniques.
Physical Appearance
Clear and colorless solution that has been sterilized by filtration.
Formulation
The PPP1R14A protein is supplied in a solution at a concentration of 1 mg/ml. The solution also contains 20 mM Tris-HCl buffer at pH 8, 0.2 mM EDTA, 1 mM DTT (dithiothreitol), and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein, such as 0.1% HSA (human serum albumin) or BSA (bovine serum albumin), is recommended for long-term storage to maintain protein stability. Repeated freezing and thawing of the product should be avoided to prevent protein degradation.
Purity
The purity of the PPP1R14A protein is greater than 95%, as determined by SDS-PAGE analysis.
Synonyms
Protein phosphatase 1 regulatory subunit 14A, 17 kDa PKC-potentiated inhibitory protein of PP1, CPI17, CPI-17, PPP1INL, PPP1R14A.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MAAQRLGKRV LSKLQSPSRA RGPGGSPGGL QKRHARVTVK YDRRELQRRL DVEKWIDGRL EELYRGMEAD MPDEINIDEL LELESEEERS RKIQGLLKSC GKPVEDFIQE LLAKLQGLHR QPGLRQPSPS HDGSLSPLQD RARTAHP.

Product Science Overview

Biological Properties

PPP1R14A is an inhibitor of smooth muscle myosin phosphatase. Its inhibitory activity is significantly enhanced when phosphorylated. This phosphorylation-dependent inhibition of myosin phosphatase leads to increased myosin phosphorylation, which in turn enhances smooth muscle contraction .

Expression Patterns and Tissue Distribution

PPP1R14A is expressed in various tissues, with notable expression in smooth muscle tissues. The protein’s expression is regulated by different signaling pathways, including those involving protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) .

Biological Functions

The primary function of PPP1R14A is to regulate the phosphorylation status of myosin light chains in smooth muscle cells. By inhibiting myosin phosphatase, PPP1R14A increases myosin light chain phosphorylation, leading to enhanced muscle contraction. This regulation is essential for various physiological processes, including vascular tone, gastrointestinal motility, and respiratory function .

Modes of Action

PPP1R14A acts as a molecular switch that regulates the activity of myosin phosphatase. When phosphorylated, PPP1R14A binds to and inhibits myosin phosphatase, preventing the dephosphorylation of myosin light chains. This inhibition is reversible, and dephosphorylation of PPP1R14A reduces its inhibitory activity, allowing myosin phosphatase to dephosphorylate myosin light chains and relax the muscle .

Regulatory Mechanisms

The activity of PPP1R14A is regulated by phosphorylation through various kinases, including PKC and PKA. These kinases phosphorylate PPP1R14A at specific serine and threonine residues, enhancing its inhibitory activity. Additionally, the dephosphorylation of PPP1R14A by protein phosphatases reduces its inhibitory activity, providing a dynamic regulatory mechanism for smooth muscle contraction .

Clinical Relevance

Alterations in the expression or activity of PPP1R14A have been associated with various diseases, including hypertension and asthma. Understanding the regulatory mechanisms of PPP1R14A can provide insights into the development of therapeutic strategies for these conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.